Race Oncology
Australia - Sydney
BiotechnologyFocus: RNA-directed Therapies
Race Oncology is a life sciences company focused on RNA-directed Therapies.
OncologyGene Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Bisantrene Dihydrochloride
Acute Myeloid LeukemiaClinical Trials (1)
NCT05456269A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
Phase 1RC220
Solid TumoursClinical Trials (1)
NCT06815575A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
Phase 1Bisantrene
Acute Myelogenous LeukemiaClinical Trials (1)
NCT03820908Bisantrene for Relapsed /Refractory AML
Phase 2Bisantrene
Myelogenous Leukemia, AcuteClinical Trials (1)
NCT04989335Bisantrene Combination for Resistant AML
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials